Editor-in-Chief
Assistant Professor of Molecular Genetics and Biochemistry
Department of Molecular Genetics and Biochemistry
German International University
Egypt
Editor-in-Chief
Associate Professor Internal Medicine
DiMI Department of Internal Medicine
University of Genova
Italy
Editor-in-Chief
Professor
Faculty of Chemistry
California South University (CSU)
United States (USA)
Editor-in-Chief
Professor
Chemistry
King Fahd University of Petroleum & Minerals
Saudi Arabia
Editor-in-Chief
Assistant Professor
Pharmaceutical Analysis Research Center
Tabriz University of Medical Sciences
Iran
Editor-Member
Professor
Faculty of Pharmacy
University of Medicine, Pharmacy, Science and Technology of Targu Mures
Romania
The Journal of Pharma and Drug Innovation (JPDI) is an international, peer-reviewed, open-access journal dedicated to advancing scientific knowledge and innovation in the pharmaceutical and drug development sciences. The journal serves as a dynamic platform for researchers, scientists, pharmacists, and healthcare professionals to share novel findings, explore emerging trends, and promote advancements that shape the future of pharma and drug innovation.
JPDI covers a comprehensive range of topics including pharmacology, pharmaceutics, pharmacognosy, medicinal chemistry, drug design and delivery, pharmaceutical biotechnology, regulatory sciences, toxicology, and clinical pharmacy. It emphasizes innovation-driven research and supports interdisciplinary collaboration that bridges the gap between laboratory discoveries and practical applications in healthcare.
The journal welcomes a wide variety of submissions, including original research articles, review papers, short communications, case reports, and opinion pieces that contribute to scientific advancement and enhance understanding in all aspects of drug discovery, development, and therapeutic optimization.
All manuscripts undergo a rigorous double-blind peer-review process to maintain the highest standards of scientific integrity, originality, and quality. Through its open-access policy, JPDI ensures that published research is freely accessible to readers worldwide, enhancing the global dissemination of knowledge and facilitating collaboration across disciplines and regions.
With a commitment to ethical publishing, academic excellence, and transparent editorial practices, the Journal of Pharma and Drug Innovation (JPDI) strives to become a leading international resource for pharmaceutical scientists, clinicians, and industry experts pursuing excellence in drug innovation and therapeutic advancement.
Submissions may be made through our online portal or by emailing manuscripts directly to the editorial office at editorialoffice@confseries.net
Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editorialoffice@confseries.net
Rapid Publication Service
Confseries Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Confseries is an open-access platform that publishes thousands of manuscripts from internationally renowned researchers. Every submission is evaluated by our peer reviewers for suitability, and a full description of the peer review process appears below.
At Confseries, peer review is a vital part of our publishing process, ensuring that every manuscript undergoes a rigorous and unbiased evaluation.Each submission is carefully examined by subject experts who provide constructive feedback on improvements or confirm whether the work is ready for publication. To guarantee fairness and thoroughness, manuscripts are assigned to multiple reviewers, each offering their own independent assessment. The review is conducted under a double-blind system, maintaining confidentiality for both authors and reviewers.
Authors are expected to revise their manuscripts in line with reviewer suggestions and then resubmit them for further evaluation. On resubmission, the paper is reviewed again-sometimes by the original reviewers, and at other times by new ones. This review-and-revision cycle continues until the editorial board is fully satisfied that the manuscript meets the standards required for publication.
Confseries places the highest emphasis on research integrity and quality. Our peer review process is collaborative and iterative, reflecting a shared commitment between authors, reviewers, and editorial board members to uphold excellence in scholarly publishing.
